Table 3—

Baseline characteristics and prevalence of the metabolic syndrome and its components in subjects who developed and did not develop a CVD event

Free of CVD eventsIncident CVD eventsP
n1,711464
Age (years)73 ± 575 ± 5<0.001
Male sex (%)38.964.7<0.001
Current smoking (%)13.215.60.18
Family history of MI (%)27.935.6<0.01
Waist (cm)92.2 ± 11.795.5 ± 10.1<0.001
BMI (kg/m2)26.0 ± 3.826.2 ± 3.20.22
SBP (mmHg)135.3 ± 18.0142.3 ± 17.4<0.001
DBP (mmHg)70.9 ± 9.572.4 ± 9.3<0.01
Pulse pressure (mmHg)64.4 ± 16.469.9 ± 16.0<0.001
Fasting plasma glucose (mg/dl)103.5 ± 23.6112.6 ± 38.5<0.001
Triglycerides (mg/dl)127.5 ± 62.3145.8 ± 75.5<0.001
HDL cholesterol (mg/dl)57.5 ± 15.550.1 ± 13.6<0.001
LDL cholesterol (mg/dl)129.8 ± 33.6134.3 ± 37.5<0.05
CCA IMT (mm)0.97 ± 0.211.10 ± 0.28<0.001
Alterations by ATPIII criteria
    Glucose domain (%)19.131.4<0.001
    Blood pressure domain (%)59.677.8<0.001
    HDL cholesterol domain (%)22.333.1<0.001
    Triglycerides domain (%)25.133.7<0.001
    Abdominal obesity domain (%)42.240.20.43
    Metabolic syndrome (%)24.038.7<0.001
Alterations by WHO criteria
    Glucose domain (%)19.131.4<0.001
    Blood pressure domain (%)43.760.9<0.001
    Lipid domain (%)26.835.3<0.001
    Obesity domain (%)43.760.0<0.001
    Metabolic syndrome (%)17.229.3<0.001
  • CCA, common carotid artery; DBP, diastolic blood pressure; MI, myocardial infarction; SBP, systolic blood pressure.